Further mRNA expression was correlated with disease-specific auto-antibodies, and results revealed that patients positive for ACA autoantibody had significantly higher IRF7 mRNA fold change compared to ACA-negative SSc patients (fold change=4.95; p=0.008; Figure 1F). The gene discussed is IRF7; the disease is systemic sclerosis.